ArticleScientific reports2026
Perinatal mood and anxiety diagnoses and treatment increased among medicaid births, 2017-2021.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Despite funding the most births in the United States (US), we know little about basic patterns and trends of mental health conditions among Medicaid-insured women during pregnancy and after delivery. We sought to characterize the prevalence of diagnosis and treatment for perinatal mood and anxiety disorders (PMAD) among women with Medicaid health insurance coverage. We conducted serial, cross-sectional analyses of women with live-birth deliveries during 2017-2021 using Transformed Medicaid Statistical Information System (T-MSIS) claims. To construct state-specific PMAD diagnosis and treatment trajectories including antidepressant prescriptions and psychotherapy visits, we examined geographic variations by state and year among reproductive aged women. In a national cohort of 4,579,289 women with Medicaid and a live birth, 635,785 (13.88%) had a PMAD diagnosis during the study period. Perinatal women in all age, race, ethnicity, geographic regions, comorbidity burdens, and all but one state experienced growth in PMAD diagnoses. Substantial variation occurred among states for antidepressant use, while national trends remained stable. Characterizing PMAD diagnosis and treatment patterns represents an important public health contribution. Future research should aim to better understand factors underlying variation in PMAD diagnoses and treatment across subgroups and geographic areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.